| Jude Christopher Barber, MD | |
|
1301 N Columbia Rd Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202-9037 | |
| (701) 293-4151 | |
| Not Available |
| Full Name | Jude Christopher Barber |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1301 N Columbia Rd Stop 9037, Grand Forks, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679197818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | RL16612 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jude Christopher Barber, MD 1301 N Columbia Rd Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202-9037 Ph: (701) 293-4151 | Jude Christopher Barber, MD 1301 N Columbia Rd Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202-9037 Ph: (701) 293-4151 |
News Archive
An important goal of early-phase clinical trials is to discover a drug's possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug side effects are reported, potentially making some drugs seem safer or less safe than they really are.
GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, today announced that a pilot study of the company's lead candidate, GMI-1070, is underway in sickle cell patients. The first patients in this pilot study were treated at Children's Hospital & Research Center Oakland in California.
laxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures.
The U.S. Drug Enforcement Administration (DEA) had to resort to its emergency powers this Wednesday to ban K2 and other "fake pot" products that mimic the effects of marijuana. As of now it is illegal to possess or sell the five chemicals used to make the products for at least one year. The agency and the Department of Health and Human Services will further debate whether the chemicals should be permanently added to the federal list of controlled substances considered unsafe, highly abused and without medical use.
"Artemisinin, a crucial drug in the global fight against malaria, could soon become cheaper and easier to make, thanks to researchers who have found a better way to synthesize the compound," Science NOW reports, providing an overview of the research published in Angewandte Chemie on Monday.
› Verified 4 days ago
Seye Adekeye, M.D., PH.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 N Columbia Rd Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202 Phone: 701-777-3067 | |
Bradley P Belluk, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-2300 Fax: 701-780-1942 | |
Dr. Wade Anthony Hopper, DO Surgery Medicare: Medicare Enrolled Practice Location: 1301 N Columbia Rd Stop 9037, Grand Forks, ND 58202 Phone: 701-777-3069 | |
Katherine Alice Senter, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 S Columbia Rd, Grand Forks, ND 58201 Phone: 701-780-5000 Fax: 701-780-4477 | |
Adrian Sarli, MD Surgery Medicare: Medicare Enrolled Practice Location: 1301 N Columbia Rd, Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202 Phone: 701-293-4151 | |
Ergest Isak, MD Surgery Medicare: Medicare Enrolled Practice Location: 1301 N Columbia Rd Stop 9037, Grand Forks, ND 58202 Phone: 701-777-3069 | |
Nicole D Lee, Surgery Medicare: Medicare Enrolled Practice Location: 1301 N Columbia Rd, Stop 9037, Und Department Of Surgery, Grand Forks, ND 58202 Phone: 701-777-3069 |